Bind Therapeutics proposes IPO

Bind Therapeutics Inc., Cambridge, Mass. Business: Cancer, Drug delivery Date announced: 8/12/13 Type: IPO To be raised: Up to $80.5 million Shares: TBD Price: TBD Underwriters: Credit Suisse; Cowen; ...